Gefitinib concentrations in human glioblastoma tissue (original) (raw)

We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Access this article

Log in via an institution

Subscribe and save

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Hofer S, Frei K, Rutz HP (2006) Gefitinib accumulation in glioblastoma tissue. Cancer Biol Ther 5:483–484
    Article PubMed CAS Google Scholar
  2. Uhm JH, Haas-Kogan DA, Mischel PS (2006) Epidermal growth factor receptor in glioma: biology, prognosis and clinical trials. In: Educational book, Am Soc Clin Oncol, pp 85–91
  3. Zhao M, Hartke C, Jimeno A et al (2005) Specific method for determination of gefitinib in human plasma, mouse plasma and tissues using high performance liquid chromatography coupled to tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 819:73–80
    Article PubMed CAS Google Scholar

Download references

Author information

Authors and Affiliations

  1. Medical Oncology, University Hospital Zürich, Rämistrasse 100, 8091, Zürich, Switzerland
    Silvia Hofer
  2. Department of Neurosurgery, University Hospital Zürich, Zürich, Switzerland
    Karl Frei

Authors

  1. Silvia Hofer
    You can also search for this author inPubMed Google Scholar
  2. Karl Frei
    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toSilvia Hofer.

Rights and permissions

About this article

Cite this article

Hofer, S., Frei, K. Gefitinib concentrations in human glioblastoma tissue.J Neurooncol 82, 175–176 (2007). https://doi.org/10.1007/s11060-006-9257-3

Download citation

Keywords